ID

38227

Beskrivning

The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01996410

Länk

https://clinicaltrials.gov/show/NCT01996410

Nyckelord

Versioner (1)
  1. 2019-09-29 2019-09-29 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

29 september 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Breast Cancer Stages I Through III NCT01996410

Engelsk

Eligibility Breast Cancer Stages I Through III NCT01996410

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
18 years or older
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
english speaking/reading/writing
Beskrivning

Able to speak English Language | Able to read English Language | Able to write English Language

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0564215
UMLS CUI [1,2]
C0376245
UMLS CUI [2,1]
C0586740
UMLS CUI [2,2]
C0376245
UMLS CUI [3,1]
C0584993
UMLS CUI [3,2]
C0376245
breast cancer stages i through iii
Beskrivning

Breast Carcinoma TNM Breast tumor staging

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0474926
any performance status suitable for chemotherapy as determined by the physician
Beskrivning

Performance status Suitable Chemotherapy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1518965
UMLS CUI [1,2]
C3900053
UMLS CUI [1,3]
C0392920
primary or secondary chemotherapy, but enrolling patients prior to a chemotherapy regimen regardless of previous radiation therapy exposure and/or previous mastectomy.
Beskrivning

Chemotherapy Primary | Chemotherapy Secondary

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205225
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0175668
scheduled to receive either of the following two regimens:
Beskrivning

Regimen Scheduled

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0040808
UMLS CUI [1,2]
C0205539
adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (175 mg/m2)
Beskrivning

Adriamycin Dosage | Cytoxan Dosage | Taxol Dosage

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0085752
UMLS CUI [1,2]
C0178602
UMLS CUI [2,1]
C0699319
UMLS CUI [2,2]
C0178602
UMLS CUI [3,1]
C0678133
UMLS CUI [3,2]
C0178602
adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (80 g/m2)
Beskrivning

Adriamycin Dosage | Cytoxan Dosage | Taxol Dosage

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0085752
UMLS CUI [1,2]
C0178602
UMLS CUI [2,1]
C0699319
UMLS CUI [2,2]
C0178602
UMLS CUI [3,1]
C0678133
UMLS CUI [3,2]
C0178602
taxotere (75mg/m2), cytoxan (600 mg/m2)
Beskrivning

Taxotere Dosage | Cytoxan Dosage

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0699967
UMLS CUI [1,2]
C0178602
UMLS CUI [2,1]
C0699319
UMLS CUI [2,2]
C0178602
taxotere (75 mg/m2), carboplatin (auc 6), perjeta (840 mg loading fixed dose, followed by 420 mg maintenance fixed dose)
Beskrivning

Taxotere Dosage | Carboplatin AUC | Perjeta Dosage

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0699967
UMLS CUI [1,2]
C0178602
UMLS CUI [2,1]
C0079083
UMLS CUI [2,2]
C0376690
UMLS CUI [3,1]
C3473371
UMLS CUI [3,2]
C0178602
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of narcolepsy
Beskrivning

Narcolepsy

Datatyp

boolean

Alias
UMLS CUI [1]
C0027404
sleep apnea requiring cpap
Beskrivning

Sleep Apnea Requirement CPAP

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0037315
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0199451
other acupuncture treatment within one month of enrollment
Beskrivning

Acupuncture

Datatyp

boolean

Alias
UMLS CUI [1]
C0394664
acupuncture treatment for chemotherapy in the past
Beskrivning

Acupuncture Associated with Chemotherapy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0394664
UMLS CUI [1,2]
C0332281
UMLS CUI [1,3]
C0392920
current participation in any other research studies
Beskrivning

Study Subject Participation Status | Research study

Datatyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0681814
Tillbaka till toppen

Similar models

Eligibility Breast Cancer Stages I Through III NCT01996410

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
18 years or older
boolean
C0001779 (UMLS CUI [1])
Able to speak English Language | Able to read English Language | Able to write English Language
Item
english speaking/reading/writing
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0586740 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
C0584993 (UMLS CUI [3,1])
C0376245 (UMLS CUI [3,2])
Breast Carcinoma TNM Breast tumor staging
Item
breast cancer stages i through iii
boolean
C0678222 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
Performance status Suitable Chemotherapy
Item
any performance status suitable for chemotherapy as determined by the physician
boolean
C1518965 (UMLS CUI [1,1])
C3900053 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
Chemotherapy Primary | Chemotherapy Secondary
Item
primary or secondary chemotherapy, but enrolling patients prior to a chemotherapy regimen regardless of previous radiation therapy exposure and/or previous mastectomy.
boolean
C0392920 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
Regimen Scheduled
Item
scheduled to receive either of the following two regimens:
boolean
C0040808 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
Adriamycin Dosage | Cytoxan Dosage | Taxol Dosage
Item
adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (175 mg/m2)
boolean
C0085752 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0699319 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0678133 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
Adriamycin Dosage | Cytoxan Dosage | Taxol Dosage
Item
adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (80 g/m2)
boolean
C0085752 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0699319 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0678133 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
Taxotere Dosage | Cytoxan Dosage
Item
taxotere (75mg/m2), cytoxan (600 mg/m2)
boolean
C0699967 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0699319 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
Taxotere Dosage | Carboplatin AUC | Perjeta Dosage
Item
taxotere (75 mg/m2), carboplatin (auc 6), perjeta (840 mg loading fixed dose, followed by 420 mg maintenance fixed dose)
boolean
C0699967 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0079083 (UMLS CUI [2,1])
C0376690 (UMLS CUI [2,2])
C3473371 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Narcolepsy
Item
history of narcolepsy
boolean
C0027404 (UMLS CUI [1])
Sleep Apnea Requirement CPAP
Item
sleep apnea requiring cpap
boolean
C0037315 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0199451 (UMLS CUI [1,3])
Acupuncture
Item
other acupuncture treatment within one month of enrollment
boolean
C0394664 (UMLS CUI [1])
Acupuncture Associated with Chemotherapy
Item
acupuncture treatment for chemotherapy in the past
boolean
C0394664 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
Study Subject Participation Status | Research study
Item
current participation in any other research studies
boolean
C2348568 (UMLS CUI [1])
C0681814 (UMLS CUI [2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial